FIELD: medicine.
SUBSTANCE: invention relates to medicine and represents a pharmaceutical anticancer gel containing 0.5 g of doxorubicin, 100 ml of PEG-12 dimethicone, 50 ml of gelling agent, 20 ml of triethanolamine and purified water - to 1,000.0 ml. Gel contains doxorubicin, encapsulated in niosomes formed by PEG-12 dimethicone.
EFFECT: technical result is higher efficiency of doxorubicin and reduced cardiotoxicity due to encapsulation in niosomes.
1 cl, 1 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL NIOSOMAL GEL BASED ON N-HYDROXY-2-(2-(NAPHTALENE-2-YL)-1H-INDOLE-3-YL)-2-PHENYLACETAMIDE WITH ANTI-TUMOUR ACTIVITY TO GLIOBLASTOMA | 2015 |
|
RU2627449C2 |
| TRANSDERMAL ANTHELMINTIC AGENT OF SILICONE NIOSOMES WITH ALBENDAZOLE | 2013 |
|
RU2541156C1 |
| METHOD FOR TRANSDERMAL TRANSFER OF ACTIVE SUBSTANCES WITH USE OF PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539396C2 |
| METHOD FOR MAKING TRANSDERMAL PATCH CONTAINING PEG-12 DIMETHICONE NIOSOMES | 2012 |
|
RU2539397C2 |
| NIOSOMAL ANTIMICROBIAL GEL FOR TREATING DIABETIC ULCERS, WOUNDS, BURNS, INCLUDING THOSE INFECTED WITH ANTIBIOTIC-RESISTANT MICROORGANISMS | 2021 |
|
RU2781402C2 |
| METHOD OF PRODUCING NIOSOMAL FORM OF OFLOXACIN | 2014 |
|
RU2583135C1 |
| DENTAL GEL HAVING NIOSOMES FOR TREATMENT OF INFLAMMATORY AND DYSTROPHIC PERIODONTAL DISEASES | 2013 |
|
RU2582290C2 |
| ANTIMICROBIAL GEL FOR THE TREATMENT OF INFECTED WOUNDS, BURNS AND TROPHIC ULCERS | 2017 |
|
RU2655522C1 |
| LIPOSOMAL COMPOSITIONS APPLICABLE FOR DRUG DELIVERY | 2005 |
|
RU2574926C2 |
| SILICON-ORGANIC NIOSEMES WITH BACTERICIDAL AND PARAMAGNETIC PROPERTIES | 2016 |
|
RU2625722C1 |
